219 related articles for article (PubMed ID: 15631648)
1. [Residual collagen binding assay for von Willebrand factor-cleaving protease activity and its clinical application].
Gao WQ; Su J; Xing XP; Wang JH; Bai X; Wang ZY; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):726-9. PubMed ID: 15631648
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
[TBL] [Abstract][Full Text] [Related]
3. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
4. [Clinical application of a method for evaluating von Willebrand factor cleaving protease activity].
Lin FQ; Li MF; Liu Q; Li ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1176-9. PubMed ID: 17715019
[TBL] [Abstract][Full Text] [Related]
5. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
[TBL] [Abstract][Full Text] [Related]
6. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
[TBL] [Abstract][Full Text] [Related]
7. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
[TBL] [Abstract][Full Text] [Related]
8. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and clinical application of a new method for detecting ADAMTS13 activity.
Wang AY; Dong NZ; Ma ZN; Zhang JY; Su J; Ruan CG
Chin Med J (Engl); 2010 Jul; 123(14):1859-63. PubMed ID: 20819568
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
11. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura.
Rick ME; Moll S; Taylor MA; Krizek DM; White GC; Aronson DL
Thromb Haemost; 2002 Oct; 88(4):598-604. PubMed ID: 12362230
[TBL] [Abstract][Full Text] [Related]
13. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
Suvajdzić-Vuković N
Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
[TBL] [Abstract][Full Text] [Related]
15. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
[TBL] [Abstract][Full Text] [Related]
17. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
Budde U; Schneppenheim R
Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
[TBL] [Abstract][Full Text] [Related]
18. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
[TBL] [Abstract][Full Text] [Related]
20. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
